Company Monitoring Page for Biogen

latest headlines for company on cafepharma

With Action Date Imminent, Biogen's Aducanumab Invokes Hope and Skepticism
BioSpace
Thu, 06/3/21 - 10:59 pm
Tags:
Biogen, aducanumab, FDA, Alzheimer's disease
If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it
Stat
Mon, 05/31/21 - 06:56 pm
Tags:
physicians, Biogen, aducanumab, Alzheimer's disease, FDA
'A hugely consequential decision:' How Biogen's Alzheimer's drug came to face the FDA
BioPharma Dive
Thu, 05/27/21 - 11:52 pm
Tags:
Biogen, FDA, aducanumab, Alzheimer's disease
Go or no go? Aducanumab’s day of reckoning
EP Vantage
Thu, 05/27/21 - 10:56 am
Tags:
Biogen, FDA, aducanumab, Ascendis Pharma, Novo Nordisk, TransCon hGH, semaglutide
Alzheimer's patients face several hurdles if Biogen's Alzheimer's drug is OK'd
Beckers Hospital Review
Wed, 05/26/21 - 11:18 am
Tags:
Biogen, Alzheimer's disease, aducanumab, FDA
Biogen and Ginkgo Bioworks team up to develop novel gene therapy manufacturing platform
Biopharma Reporter
Mon, 05/24/21 - 10:43 am
Tags:
Biogen, Ginkgo Bioworks, gene therapy
Biogen gene therapy for rare eye disease falls short in key clinical trial
MedCity News
Sun, 05/16/21 - 11:26 pm
Tags:
Biogen, gene therapy, clinical trials, X-linked retinitis pigmentosa, cotoretigene toliparvovec
Biogen taps Envisagenics’ AI to speed up RNA splicing R&D
Pharmaforum
Fri, 05/14/21 - 10:44 am
Tags:
Biogen, RNA, drug discovery, Envisagenics, artificial intelligence
Biogen buys midphase drug to challenge Roche for stroke market
Fierce Biotech
Wed, 05/12/21 - 11:07 am
Tags:
Biogen, acute ischemic stroke, stroke, TMS
Biogen looks to build better gene therapies through latest deal
BioPharma Dive
Tue, 05/11/21 - 11:45 am
Tags:
Biogen, gene therapy, Capsigen
Drug pricing watchdog joins the chorus of critics on Biogen's aducanumab: What about charging $2,560 per year?
Endpoints
Thu, 05/6/21 - 10:57 am
Tags:
Biogen, aducanumab, Alzheimer's disease, drug pricing, ICER
Zolgensma flatlines, but Spinraza isn’t the beneficiary
EP Vantage
Wed, 04/28/21 - 10:27 am
Tags:
SMA, Biogen, Novartis, Roche, Spinraza, Zolgensma, Evrysdi
Following pressure, Biogen to start compassionate use program for ALS drug tofersen
Seeking Alpha
Tue, 04/27/21 - 10:58 am
Tags:
Biogen, ALS, tofersen, compassionate use guidelines
Bio­gen's Michel Vounatsos takes home $18.7M in pay as the com­pa­ny bat­tles to take ad­u­canum­ab to mar­ket
Endpoints
Tue, 04/27/21 - 10:48 am
Tags:
Biogen, Pharma CEOs, Michel Vounatsos, executive pay, aducanumab
Why Biogen's Better-Than-Expected Q1 Results Weren't Good Enough
Motley Fool
Thu, 04/22/21 - 11:09 am
Tags:
Biogen, earnings
Biogen’s Alzheimer’s hopeful aducanumab faces ‘less than a coin flip’s chance’ of FDA approval: analysts
Fierce Pharma
Wed, 04/21/21 - 11:29 pm
Tags:
Biogen, aducanumab, Alzheimer's disease
Biogen Reports New Spinraza Data in SMA
Global Genes
Wed, 04/21/21 - 10:34 am
Tags:
Biogen, Spinraza, SMA
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Tue, 04/20/21 - 11:16 pm
Tags:
Biogen, aducanumab, FDA, Vertex Pharmaceuticals, Sarepta Therapeutics, JNJ, AstraZeneca, vaccines, COVID-19
A new market beckons for Alzheimer’s blood tests
EP Vantage
Mon, 04/19/21 - 11:12 am
Tags:
Alzheimer's disease, diagnostics, donanemab, Eli Lilly, Biogen, Quanterix
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
Tags:
M&A, Alexion, Amgen, AstraZeneca, Biogen, Five Prime Therapeutics, Gilead Sciences, GW Pharma, Horizon Therapeutics, Immunomedics, Jazz Pharmaceutical, Kymab, Merck, Pandion, Sanofi, Viela Bio

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.